Firms
Theme

GFF

Griffon Corp · NYSE

News

7 latest

Zacks Investment Research

Griffon (GFF) Surpasses Market Returns: Some Facts Worth Knowing

Griffon (GFF) closed at $94.99, up 2.51% in the latest session, outperforming the S&P 500. However, the stock has declined 2.59% over the past month.

Zacks Investment Research

Are Conglomerates Stocks Lagging Grupo Cibest S.A. - Sponsored ADR (CIB) This Year?

Grupo Cibest (CIB) has significantly outperformed the Conglomerates sector in 2026, returning 47.9% year-to-date compared to a -17.9% average loss for the sector. The company holds a Zacks Rank #1 (Strong Buy) with analyst consensus earnings estimates rising 22.5% over the past 90 days. Griffon (GFF) is another standout performer in the sector with a 25.1% return and an 11% increase in EPS estimates.

Zacks Investment Research

New Strong Buy Stocks for October 9th

Zacks has added five stocks to its Strong Buy list based on positive earnings estimate revisions over the last 60 days. The stocks include Lumentum Holdings (optical/photonic products), Werewolf Therapeutics (cancer biopharmaceutical), Perion Network (digital advertising), Goldman Sachs BDC (business development), and Griffon Corporation (diversified management).

Zacks Investment Research

Best Value Stocks to Buy for October 9th

Zacks highlights three stocks with Rank #1 (Strong Buy) ratings and strong value characteristics: Perion Network Ltd. (PERI) with a P/E of 7.42 and 14.7% earnings estimate increase; Griffon Corporation (GFF) with a P/E of 14.91 and 5.5% earnings estimate increase; and Goldman Sachs BDC, Inc. (GSBD) with a P/E of 6.85 and 12.2% earnings estimate increase.

Mentions GFF

Zacks Investment Research

MMM Q3 Earnings on Deck: How to Approach the Stock Now?

3M is expected to report Q3 2026 revenue of $6.60 billion and EPS of $2.41 on October 20. The company's Safety and Industrial and Transportation and Electronics segments are expected to perform well, supported by restructuring efforts.

Zacks Investment Research

Carlisle Exhibits Strong Prospects Despite Persisting Headwinds

Carlisle Companies (CSL) reported 8% revenue growth in its Construction Materials segment and 10% growth in Weatherproofing Technologies in Q2 2026, driven by strong re-roofing demand and market-share gains. However, elevated petroleum-based raw material and freight costs, exacerbated by Middle East geopolitical tensions, pressured margins as cost of sales increased 10.3%. The company raised its share repurchase target to $1.2 billion and increased its quarterly dividend by 14%, marking its 50th consecutive annual dividend increase.

Zacks Investment Research

Here's Why It is Appropriate to Invest in ITT Stock Right Now

ITT Inc. (ITT) is well-positioned for near-term growth driven by strength across its Flow Technologies, Connect and Control Technologies, and Motion Technologies segments. The company's recent acquisitions of Aerospace Contacts and SPX FLOW are expanding capabilities, while continued innovation investments and shareholder rewards through dividends and buybacks support its investment appeal. ITT carries a Zacks Rank #2 (Buy) rating.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $GFF · 0 threads

Sign in to post on $GFF

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev